MedTrace Logo

Hematopoietic Stem Cell Transplantation Empowerment Program

NCT07781046 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-08-24

No results posted yet for this study

Summary

The goal of this study is to evaluate the impact of an empowerment program for patients undergoing stem cell transplantation on their clinical outcomes.

The research hypothesis are:

* Patients who participate in the proposed empowerment program will exhibit a significant improvement in their knowledge related to stem cell transplantation than those who don't.
* Patients who participate in the proposed empowerment program will exhibit a significant improvement in their self-care practices than those who don't.
* Patients who participate in the proposed empowerment program will exhibit a significant improvement in their health-related quality of life than those who don't.

The study sample was divided into control and study groups. Study group (A) who was received routine care in addition to empowerment program, while control group (B) who was received routine care only.

Conditions

  • Stem Cell Transplantation, Hematopoietic

Interventions

BEHAVIORAL

Empowerment program

A structured nursing-led empowerment program designed to improve patients' knowledge, self-care skills, and quality of life.

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Ola Ebrahim Elsherbiny, Assistant professor · Faculty of Nursing, Mansoura University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-02-01
Completion
2026-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07781046 on ClinicalTrials.gov